Clinical Trial

EORTC Quality of Life Measurement in Males With Breast Cancer

Study acronym: BR Male
Completed
View on ClinicalTrials.gov →
Summary
Around 1% of all new cases of breast cancer (BC) diagnosed annually occur in men. Most research to date has focused on female breast cancer (FBC). So what is known about breast cancer in men has been mostly derived from the research and treatment of FBC. Comprehensive, prospective data about Quality of life in men treated for BC is lacking. Therefore, a validated worldwide questionnaire for male BC will be developed.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-03-02.
Trial Details
NCT Number NCT07455110
Lead Sponsor Helios University Hospital Wuppertal
Collaborators: Mugla Sitki Kocman University School of Medicine, UNED Pamplona, Unidad de cancer, Sorlandet Hospital HF, Medical University Innsbruck, Sunnybrook Health Sciences Centre, East Kent Gynaecological Oncology Centre, Queen Elizabeth the Queen Mother Hospital, Rigshospitalet, Denmark, University of Southern Denmark, University of Roma La Sapienza
Conditions Male Breast Cancer, Quality of Life, Breast Cancer
Enrollment 65 participants
Start Date 2019-11-01
Primary Completion 2023-03-20 (estimated)
Study Completion 2023-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-27